Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of Aroxybutynin/Atomoxetine (AD109) to Placebo in Obstructive Sleep Apnea (SynAIRgy Study)
1 other identifier
interventional
646
2 countries
73
Brief Summary
This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Sep 2023
73 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2023
CompletedFirst Posted
Study publicly available on registry
April 14, 2023
CompletedStudy Start
First participant enrolled
September 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2025
CompletedNovember 21, 2025
November 1, 2025
1.5 years
April 3, 2023
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Apnea-Hypopnea Index (AHI)
AHI, Apnea-Hypopnea Index, is the number of apneas or hypopneas recorded via polysomnography during the study per hour of sleep. Apnea is defined as a cessation of airflow lasting at least 10 seconds, hypopnea as a decrease in airflow by at least 30% from baseline for at least 10 seconds occurring with a drop in oxygen saturation (SpO2) by at least 4%.
6 months
Study Arms (2)
AD109
EXPERIMENTALAD109
Placebo
PLACEBO COMPARATORPlacebo
Interventions
Eligibility Criteria
You may qualify if:
- ≥18 years of age at the time of informed consent.
- PSG criteria: AHI of ≥10 and ≤45; ≤ 25% central or mixed apneas; and PLM arousal index ≤15
- PROMIS-Fatigue: raw score ≥17
- PAP intolerance or current PAP refusal.
- BMI between 18.5 and 40 kg/m2 for men, or 42 kg/m2 for women, inclusive.
You may not qualify if:
- Narcolepsy, restless leg syndrome, REM sleep behavior disorder
- Insomnia disorder characterized by difficulty initiating or maintaining sleep, or use within the past month of sedative-hypnotics or other medication for the purpose of treating or avoiding insomnia symptoms.
- Pierre Robin, Treacher Collins, or other craniofacial malformation syndrome, or grade ≥3 tonsillar hypertrophy.
- Clinically significant cardiac disease, e.g., ventricular arrhythmia, untreated or unstable coronary artery disease, cardiac failure. Stable atrial arrhythmia is allowed.
- Neuromuscular disorder (e.g., motor neuron disease, muscular dystrophy or myopathy, myasthenic syndrome); epilepsy; Parkinson, Alzheimer, or other neurodegenerative disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Apnimedlead
Study Sites (73)
Alabama Neurology & Sleep Medicine
Tuscaloosa, Alabama, 35406, United States
Desert Clinical Research - CCT Research
Mesa, Arizona, 85213, United States
Foothills Research Center - CCT Research
Phoenix, Arizona, 85044, United States
Fiel Family Sports Medicine - PC CCT Research
Tempe, Arizona, 85283, United States
Noble Clinical Research
Tucson, Arizona, 85704, United States
Preferred Research Partners, Inc.
Little Rock, Arkansas, 72211, United States
Orange County Research Institute
Anaheim, California, 92801, United States
North County Neurology Associates
Carlsbad, California, 92011, United States
Core Healthcare Group
Cerritos, California, 90703, United States
Exalt Clinical Research
Chula Vista, California, 91910, United States
Catalina Research Institute
Montclair, California, 91763, United States
Probe Clinical Research Corporation
Riverside, California, 92501, United States
Pacific Research Network
San Diego, California, 92103, United States
Sleep Medicine Specialists of California
San Ramon, California, 94583, United States
SDS Clinical Trials Inc.
Santa Ana, California, 92705, United States
Provideré Research Inc.
West Covina, California, 91790, United States
Meris Clinical Research
Brandon, Florida, 33511, United States
Nouvelle Clinical Research
Cutler Bay, Florida, 33189, United States
Accel Research Sites
DeLand, Florida, 32720, United States
Research Centers of America, LLC
Hollywood, Florida, 33024, United States
Canvas Clinical Research
Lake Worth, Florida, 33467, United States
Florida Lung and Sleep Associates
Lehigh Acres, Florida, 33971, United States
Advanced Medical Research Institute
Miami, Florida, 33174, United States
Clinical Site Partners
Miami, Florida, 33186, United States
Clinical Neuroscience Solutions, Inc - Orlando
Orlando, Florida, 32801, United States
JSV Clinical Research Study Inc
Tampa, Florida, 33634, United States
Florida Pediatric Research Institute
Winter Park, Florida, 32789, United States
Atlanta Center for Medical Research, LLC
Atlanta, Georgia, 30031, United States
NeuroTrials Research
Atlanta, Georgia, 30342, United States
Georgia Neurology and Sleep Medicine Assoc
Suwanee, Georgia, 30024, United States
Javarra Inc-Privia Medical Group
Thomasville, Georgia, 31792, United States
St. Lukes Clinic - Idaho Pulmonary Associates
Meridian, Idaho, 83642, United States
Chicago Research Center Inc
Chicago, Illinois, 60634, United States
OSF HealthCare Saint Francis Medical Center
Peoria, Illinois, 61637, United States
The University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Advanced ENT and Allergy
Louisville, Kentucky, 40220, United States
Centennial Medical Group
Elkridge, Maryland, 21075, United States
Infinity Medical Research
North Dartmouth, Massachusetts, 02747, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
Revive Research Institute
Lathrup Village, Michigan, 48076, United States
Las Vegas Clinical Trials
North Las Vegas, Nevada, 89030, United States
Neurology Specialists of Monmouth County
West Long Branch, New Jersey, 07764, United States
Javara Inc - Tryon Medical Partners PLCC
Charlotte, North Carolina, 28210, United States
Research Carolina Elite
Denver, North Carolina, 28025, United States
Peters Medical Research, LLC
High Point, North Carolina, 27260, United States
PMG Research of Wilmington
Wilmington, North Carolina, 28401, United States
Lillestol Research LLC
Fargo, North Dakota, 58104, United States
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
Sleep Management Institute (Intrepid)
Cincinnati, Ohio, 45245, United States
UC Health Sleep Medicine
Cincinnati, Ohio, 45267, United States
University Hospital of Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Abington Neurological Associate
Abington, Pennsylvania, 19001, United States
Respiratory Specialists
Wyomissing, Pennsylvania, 19610, United States
Tribe Clinical Research LL
Greenville, South Carolina, 29607, United States
OnSite Clinical Solutions LLC/Carolina Cardiology Associates P.A
Rock Hill, South Carolina, 29732, United States
Chattanooga Research & Medicine, PLLC
Chattanooga, Tennessee, 37404, United States
FutureSearch Trials of Neurology
Austin, Texas, 78731, United States
FutureSearch Trials of Dallas, LP
Dallas, Texas, 75231, United States
The Heights Hospital (HD Heights)
Houston, Texas, 77008, United States
Weill Cornell Medical College
Houston, Texas, 77030, United States
Lone Star Lung and Sleep Clinic
Houston, Texas, 77070, United States
Huntsville Research Institute LLC
Huntsville, Texas, 77340, United States
Epic Medical Research
Red Oak, Texas, 75154, United States
Element Research Group
San Antonio, Texas, 78229, United States
South Ogden Family Medicine / CCT Research
South Ogden, Utah, 84405, United States
Canadian Sleep Consultants
Calgary, Alberta, T2Z 3R6, Canada
Medical Arts Health Research
Kelowna, British Columbia, V1Y 9N7, Canada
AMNDX
Markham, Ontario, L3R 1A3, Canada
West Ottawa Sleep Centre
Ottawa, Ontario, K2C 0P7, Canada
Canadian Phase Onward Inc.
Toronto, Ontario, M3J 0K2, Canada
Toronto Sleep Institute
Toronto, Ontario, M4P 1P2, Canada
Sleep and Alertness Center
Toronto, Ontario, M5S 3A3, Canada
McGill University Health Centre
Montreal, Quebec, QC H4A, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2023
First Posted
April 14, 2023
Study Start
September 16, 2023
Primary Completion
March 10, 2025
Study Completion
March 14, 2025
Last Updated
November 21, 2025
Record last verified: 2025-11